Completed
Regorafenib Post-marketing Surveillance
NCT01843400
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Multiple Locations, Japan
Clinical trial condition
Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.
NCT01843400
NCT02800330
NCT02848638
Not specified
NCT01712347
NCT02231203
NCT02735941
NCT02287597
NCT02368236
Not specified
NCT00749450
NCT03602417